Resonance Health Ltd (AU:RHT) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Resonance Health Ltd (ASX: RHT) has requested a trading halt on its securities as it prepares to announce a significant contract related to a clinical trial with a major pharmaceutical company. The halt will remain in place until the announcement is made or normal trading resumes on 20 November 2024. This move aims to manage the company’s disclosure obligations effectively.
For further insights into AU:RHT stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ‘The Golden Path Is Within Reach,’ Says Daniel Ives About Tesla Stock
- ‘Next Two Years Will Be Crucial,’ Says Craig-Hallum About IonQ Stock
- Walmart (NYSE:WMT) Expects a Win in 2025
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
